| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S002210000446 |
| P698 | PubMed publication ID | 11026726 |
| P50 | author | Wojciech Danysz | Q114527306 |
| P2093 | author name string | G L Wenk | |
| L B Willard | |||
| B Hauss-Wegrzyniak | |||
| P433 | issue | 1 | |
| P921 | main subject | cytotoxicity | Q246181 |
| neuronitis | Q17157137 | ||
| P304 | page(s) | 58-65 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | Experimental Brain Research | Q13358841 |
| P1476 | title | The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition | |
| P478 | volume | 134 |
| Q48451450 | 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism |
| Q37043396 | ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy. |
| Q57182100 | Adolescent binge ethanol-induced loss of basal forebrain cholinergic neurons and neuroimmune activation are prevented by exercise and indomethacin |
| Q43855393 | Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2. |
| Q37596042 | Age-Related Decline in Brain and Hepatic Clearance of Amyloid-Beta is Rectified by the Cholinesterase Inhibitors Donepezil and Rivastigmine in Rats |
| Q38014513 | Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections |
| Q37627723 | Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis |
| Q40860402 | Bacterial lipopolysaccharide induces a dose-dependent activation of neuroglia and loss of basal forebrain cholinergic cells in the rat brain |
| Q36269317 | Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling |
| Q46367935 | Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors. |
| Q36268243 | COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date |
| Q38807699 | Celecoxib Alleviates Memory Deficits by Downregulation of COX-2 Expression and Upregulation of the BDNF-TrkB Signaling Pathway in a Diabetic Rat Model |
| Q33665160 | Cognitive impairment following high fat diet consumption is associated with brain inflammation. |
| Q26771644 | Estrogens, inflammation and cognition |
| Q42523801 | Evidence that toxicity of lipopolysaccharide upon cholinergic basal forebrain neurons requires the presence of glial cells in vitro |
| Q28658200 | From single target to multitarget/network therapeutics in Alzheimer's therapy |
| Q41874775 | Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. |
| Q93004738 | Hypocretinergic and cholinergic contributions to sleep-wake disturbances in a mouse model of traumatic brain injury |
| Q24794350 | Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide |
| Q35028421 | Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage |
| Q33665728 | Intracranial electrode implantation produces regional neuroinflammation and memory deficits in rats |
| Q42491893 | Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons |
| Q27025207 | Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease |
| Q47280369 | Memantine for the Treatment of Dementia: A Review on its Current and Future Applications. |
| Q36144340 | Metabotropic glutamate receptors inhibit microglial glutamate release. |
| Q34191211 | Molecular and behavioral aspects of the actions of alcohol on the adult and developing brain |
| Q26744105 | Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease |
| Q34151315 | NSAIDs may protect against age-related brain atrophy. |
| Q42473123 | Neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression. |
| Q35009772 | Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease |
| Q37841810 | Neuroinflammation and the plasticity-related immediate-early gene Arc. |
| Q37783527 | Neuroinflammation, Microglia and Implications for Anti-Inflammatory Treatment in Alzheimer's Disease |
| Q44240005 | Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40). |
| Q40961591 | Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease |
| Q35093568 | Nonsteroidal anti-inflammatory drug use and the risk for Alzheimer's disease: dissecting the epidemiological evidence |
| Q36848206 | Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation. |
| Q30490604 | Pharmacodynamics of memantine: an update |
| Q48533753 | Possible Mechanisms Involved in Attenuation of Lipopolysaccharide-Induced Memory Deficits by Methyl Jasmonate in Mice. |
| Q40690733 | Pro-inflammatory effect of freshly solubilized beta-amyloid peptides in the brain. |
| Q35140259 | Progress in clinical neurosciences: sepsis-associated encephalopathy: evolving concepts |
| Q34279077 | RETRACTED: Dose-dependent changes in neuroinflammatory and arachidonic acid cascade markers with synaptic marker loss in rat lipopolysaccharide infusion model of neuroinflammation |
| Q28389274 | Reciprocal modulation between microglia and astrocyte in reactive gliosis following the CNS injury |
| Q44029783 | Sepsis inhibits reduction of dehydroascorbic acid and accumulation of ascorbate in astroglial cultures: intracellular ascorbate depletion increases nitric oxide synthase induction and glutamate uptake inhibition |
| Q53377986 | System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40. |
| Q35218757 | The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence |
| Q35172428 | The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease |
| Q44148987 | The role of cyclo-oxygenase 1 and 2 activity in prostaglandin E(2) secretion by cultured human adult microglia: implications for Alzheimer's disease |
| Q38005630 | The role of inflammatory processes in Alzheimer's disease. |
| Q42451572 | The toxicity of tumor necrosis factor-α upon cholinergic neurons within the nucleus basalis and the role of norepinephrine in the regulation of inflammation: implications for alzheimer's disease |
| Q44357288 | Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP. |
| Q36428733 | Traumatic injury to the immature brain: inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets |
| Q36282272 | Treatment approaches to symptoms associated with frontotemporal degeneration |
| Q50862635 | Up-regulation of SGTB is associated with neuronal apoptosis after neuroinflammation induced by lipopolysaccharide. |
| Q24791744 | Vascular consequences of passive Abeta immunization for Alzheimer's disease. Is avoidance of "malactivation" of microglia enough? |
Search more.